Web of Science: 116 citations, Scopus: 124 citations, Google Scholar: citations,
Engineered LINE-1 retrotransposition in nondividing human neurons
Macia, Angela (Universidad de Granada)
Widmann, Thomas J. (Universidad de Granada)
Heras, Sara R. (Universidad de Granada)
Ayllon, Veronica (University of Granada)
Sánchez, Laura (Universidad de Granada)
Benkaddour-Boumzaouad, Meriem (Universidad de Granada)
Muñoz-Lopez, Martin (Universidad de Granada)
Rubio, Alejandro (Universidad de Granada)
Amador-Cubero, Suyapa (Universidad de Granada)
Blanco-Jimenez, Eva (Universidad de Granada)
Garcia-Castro, Javier (Instituto de Salud Carlos III. Unidad de Biotecnología Celular)
Menendez, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Ng, Philip (Baylor College of Medicine (Houston, Estats Units d'Amèrica). Department of Molecular and Human Genetics)
Muotri, Alysson R. (Hospital San Diego, University of California San Diego, La Jolla)
Goodier, John L. (Johns Hopkins University School of Medicine, Baltimore)
Garcia-Perez, Jose L. (University of Edinburgh, Western General Hospital)

Date: 2017
Abstract: Half the human genome is made of transposable elements (TEs), whose ongoing activity continues to impact our genome. LINE-1 (or L1) is an autonomous non-LTR retrotransposon in the human genome, comprising 17% of its genomic mass and containing an average of 80-100 active L1s per average genome that provide a source of inter-individual variation. New LINE-1 insertions are thought to accumulate mostly during human embryogenesis. Surprisingly, the activity of L1s can further impact the somatic human brain genome. However, it is currently unknown whether L1 can retrotranspose in other somatic healthy tissues or if L1 mobilization is restricted to neuronal precursor cells (NPCs) in the human brain. Here, we took advantage of an engineered L1 retrotransposition assay to analyze L1 mobilization rates in human mesenchymal (MSCs) and hematopoietic (HSCs) somatic stem cells. Notably, we have observed that L1 expression and engineered retrotransposition is much lower in both MSCs and HSCs when compared to NPCs. Remarkably, we have further demonstrated for the first time that engineered L1s can retrotranspose efficiently in mature nondividing neuronal cells. Thus, these findings suggest that the degree of somatic mosaicism and the impact of L1 retrotransposition in the human brain is likely much higher than previously thought.
Note: Altres ajuts: a Marie Curie IRG project (FP7-PEOPLE-2007-4-3-IRG: SOMATIC LINE-1); CICE-FEDER-P09-CTS-4980; CICE-FEDER-P12-CTS-2256; Plan Nacional de I+D+I 2008-2011 and 2013-2016 (FIS-FEDER-PI11/01489), (FIS-FEDER-PI14/02152)
Rights: Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. Creative Commons
Language: Anglès
Document: Article ; recerca ; Versió publicada
Published in: Genome research, Vol. 27 (march 2017) , p. 335-348, ISSN 1549-5469

DOI: 10.1101/gr.206805.116
PMID: 27965292


14 p, 1.8 MB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP) > Josep Carreras Leukaemia Research Institute
Articles > Research articles
Articles > Published articles

 Record created 2022-02-27, last modified 2024-12-07



   Favorit i Compartir